PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.69%
Some net income increase while MCHP is negative at -51.21%. John Neff would see a short-term edge over the struggling competitor.
8.51%
D&A growth well above MCHP's 11.58%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
245.45%
Some yoy growth while MCHP is negative at -329.56%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-121.93%
Both reduce yoy usage, with MCHP at -456.04%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-18.13%
Both reduce yoy inventory, with MCHP at -42.69%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-156.16%
Both reduce yoy usage, with MCHP at -271.64%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
171.66%
Lower 'other non-cash' growth vs. MCHP's 1273.27%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
133.53%
Some CFO growth while MCHP is negative at -117.89%. John Neff would note a short-term liquidity lead over the competitor.
24.36%
Lower CapEx growth vs. MCHP's 73.84%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-48.90%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
19.15%
Liquidation growth of 19.15% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-56.71%
We reduce yoy invests while MCHP stands at 72.96%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Lower share issuance yoy vs. MCHP's 3838.47%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
44.08%
Buyback growth of 44.08% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.